Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression-Reference-Cited by-同舟云学术

Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression

Published:2004-04 Issue:4 Volume:63 Page:682-686
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Böhle A,Bock P.R

Publisher

Elsevier BV

Subject

Urology

Reference23 articles.

1. Superficial bladder cancer;Heney;J Urol,1983

2. The T1 bladder tumor;Herr;Semin Urol,1990

3. Intravesical bacillus Calmette-Guérin versus mitomycin C for superficial bladder cancer;Böhle;J Urol,2003

4. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors;Herr;J Urol,2000

5. Maintenance bacillus Calmette-Guérin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder;Lamm;J Urol,2000

Cited by 377 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neue Therapieansätze beim nicht-muskelinvasiven Urothelkarzinom der Harnblase – Ist der Organerhalt auch nach BCG (Bacillus Calmette-Guérin) möglich?;Die Urologie;2024-08-23

2. Adverse drug reactions of intravesical instillation therapy for bladder cancer: based on FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-08-22

3. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

4. A Phase 2 Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder;Journal of Urology;2024-07

5. Use of Bladder-Related Medication in Non-Muscle Invasive Bladder Cancer Patients;Cancers;2024-05-20